Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission

E-ISSN： 1365-2249|181|2|306-313

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.2, 2015-08, pp. : 306-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 118-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1054-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemolytic Uraemic Syndrome

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c37-c42

Karger

Access to resources Recommend Favorite

Escherichia coli 'O' Group Serology of a Haemolytic Uraemic Syndrome (HUS) Epidemic

By Goldwater Paul N. Bettelheim Karl A.

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 4, 2000-10 ,pp. : 385-394

Informa Healthcare

Access to resources Recommend Favorite

Haemolytic-uraemic Syndrome Caused by Vero Toxin-producing Escherichia coli Serotype Rough: K^-: H49

By Keskimäki Markku Ratiner Yuli Oinonen Sinikka Leijala Esko Nurminen Marjatta Saari Marjut Siitonen Anja

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 2, 1999-07 ,pp. : 141-144

Informa Healthcare

Access to resources Recommend Favorite